3,4-Methylenedioxymethamphetamine causes retinal damage in C57BL/6J mice

• Published in: Human & experimental toxicology 2020-11, Vol.39 (11), p.1556-1564
• Main Authors: Ma, Y, Bian, C, Song, D, Yao, G, Nie, R
• Format: Article
• Language: English
• Subjects: Animals; Central nervous system; Cytokines; Cytokines - metabolism; Damage; DNA nucleotidylexotransferase; Ecstasy; Electroretinography; Gene expression; Gene Expression Regulation - drug effects; Growth factors; Hallucinogens - toxicity; Immunoassays; Inflammation; Matrix metalloproteinase; Matrix metalloproteinases; Matrix Metalloproteinases - metabolism; MDMA; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine - toxicity; NF-kappa B - metabolism; Polymerase chain reaction; Protein expression; Proteins; Retina; Retina - drug effects; Retina - metabolism; Retina - pathology; Retina - physiology; Retinal Diseases - chemically induced; Retinal Diseases - diagnosis; Retinal Diseases - metabolism; Retinal Diseases - pathology; Tight Junction Proteins - metabolism; Toluidine; Toluidine blue; Toxicity; Transforming growth factor-b
• ISSN: 0960-3271; 1477-0903
• DOI: 10.1177/0960327120930253

3,4-Methylenedioxymethamphetamine (MDMA) is a powerfully addictive psychostimulant with pronounced effects on the central nervous system, but the precise mechanism of MDMA-induced toxicity remains unclear, specifically on the retina. This study was performed to investigate the effects of MDMA treatment on the retina and explore the underlying mechanism. C57BL/6J mice were randomly divided into control and MDMA groups. Mice were treated with MDMA at progressively increasing doses (1-6 mg/kg) intraperitoneally 4 times per day. Electroretinography was used to test the retinal function. Pathological changes of the retina were examined by toluidine blue staining and terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling assay. Enzyme-linked immunosorbent assays were used to measure the levels of cytokines in the retina. Real-time polymerase chain reaction and Western blot were used to measure gene and protein expression in the retina, respectively. Our study showed that MDMA treatment impaired retinal function and decreased retinal thickness. MDMA treatment also increased transforming growth factor β as well as inflammatory factors in the retina. Moreover, MDMA treatment increased protein expression of matrix metalloproteinases (MMPs) and decreased tight junction protein expression in the retina. Our study indicated that treatment of MDMA caused retinal damage in C57BL/6J mice, associated with an increase of MMPs and a decrease of tight junction proteins.